IDT Licenses City of Hope s 27-Mer RNAi Tech For Research; COH Seeks Deals in Other Areas | GenomeWeb

City of Hope's Beckman Research Institute has exclusively licensed its Dicer-substrate RNAi technology to oligo manufacturer Integrated DNA Technologies for research and functional genomics applications, COH said this week.

COH is also on the lookout for parties interested in licensing the technology for therapeutic applications, and negotiations are underway with at least one RNAi-based drug developer, RNAi News has learned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.